Scinovex
review Open AccessTop 1% cited

Review article: the economic impact of the irritable bowel syndrome

Alimentary Pharmacology & Therapeutics · 2014 · Vol. 40(9) · pp. 1023–1034
C. CanavanJoe WestTim Card

Abstract

Irritable bowel syndrome is associated with substantial costs to patients, healthcare systems and society. Considerable benefit could be obtained from effective interventions.

Gastrointestinal motility and disordersCongenital gastrointestinal and neural anomaliesIntestinal and Peritoneal AdhesionsIrritable bowel syndromeMedicineAbsenteeismQuality of life (healthcare)PresenteeismPsychological interventionIndirect costsLife expectancyHealth careIntensive care medicine

MeSH terms

AbsenteeismChronic DiseaseDelivery of Health CareHealth ExpendituresHealth ResourcesHumansLife ExpectancyQuality of LifeHealth Care CostsInternationalityIrritable Bowel Syndrome

Funding

  • Nottingham University Hospitals NHS Trust
  • University of Nottingham
  • Medical Research Council
Citations
446
FWCI
19.97
field-weighted impact
References
79
Percentile
100%
vs. same field & year
Citations per year
References
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
The American Journal of Gastroenterology · 2008 · 688 citations
The burden of selected digestive diseases in the United States
Gastroenterology · 2002 · 1,507 citations
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
Alimentary Pharmacology & Therapeutics · 2005 · 487 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.